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Abstract: Nitric oxide (NO) is an essential signaling molecule within biological systems and is believed
to be involved in numerous diseases. As a result of NO’s high reaction rate, the detection of the
concentration of NO, let alone the presence or absence of the molecule, is extremely difficult. Researchers
have developed multiple assays and probes in an attempt to quantify NO within biological solutions,
each of which has advantages and disadvantages. This review highlights many of the current NO
sensors, from those that are commercially available to the newest sensors being optimized in research
labs, to assist in the understanding and utilization of NO sensors in biological fields.
Keywords: nitric oxide; sensors; biomedical engineering

1. Introduction
Nitric oxide (NO) is a molecule that has recently attracted heightened interest due to its vast role
in human health and biology. Nearly 35 years ago NO was identified as an endothelial relaxing factor,
a discovery which garnered Robert F. Furchgott, Ferid Murad, and Louis J. Ignarro a Nobel prize for
medicine or physiology in 1998 [1]. However, in the past 20 years NO has also been shown to play
a significant role in a multitude of physiological systems including the central nervous system (CNS),
the cardiovascular system, the gastrointestinal tract, the immune system, and the renal system [2–6].
Within the CNS, NO acts as a neurotransmitter, and it has been shown to regulate feelings of pain,
appetite, the sleep-wake cycle, thermoregulation, synaptic plasticity, and neural secretion [2,7–13].
NO may also act as a neuroprotective or degradative agent, depending upon its concentration within
the surrounding tissue [2,14–16]. Aside from its aforementioned role in vasodilation, NO also plays
a significant role in the modulation of platelet aggregation, smooth muscle cell proliferation, and LDL
(low density lipoprotein) cholesterol oxidation within the cardiovascular system [1,17–19].
Within the gastrointestinal tract, NO protects the stomach epithelium by stimulating mucosal
and bicarbonate secretions [4,20,21]. NO may also confer protection to the mucosal layer by inhibiting
gastric acid secretion and leukocyte adhesion to the epithelium [4,5,22,23].
The role of NO within the immune system is immense, and while much is known about some
specific roles of NO, its behavior outside of norms is still largely uncharted. A well-known role of
NO within the immune system is its antitumor and microbial effects. Macrophage-derived NO can
cause tumor cells senescence or death [5,24]. Cytotoxic lymphocytes can also induce NO expression
within tumor cells via interferon-γ and tumor necrosis factor (TNF), again resulting in senescence or
death [5,25]. Paradoxically, it is not uncommon for tumor cells to constitutively express NO, aiding in
tumor growth by increasing neovascularization and upregulating the production of DNA dependent
protein kinases (DNA-PKcs), which are required for DNA repair [5,26,27]. In addition to antitumor
effects, NO has been shown to display significant antimicrobial properties and its expression by
immune and epithelial cells has been shown to decrease replication and kill infectious agents [5,28].
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S-nitrosothiol (RSNO) is another upstream compound that is utilized to calculate NO concentration,
since it is believed that RSNOs can act as reservoirs or carriers of NO within biological systems without
altering NO’s activity [52,68,69]. The Meyerhoff lab has shown the use of sensors that can reversibly
detect RSNO within blood for a 10-day period, extending the timeframe for NO detection past most of
the other sensor options [70]. The downside of this sensor is that it is detecting an upstream component
of NO and not actual NO concentrations.
3. Electrochemical Detection
Electrochemical sensors are an excellent alternative for researchers that desire a fast and relatively
simple method of determining NO concentration. In 1992, Malinski and Taha demonstrated the ability
of their electrochemical probe, created by covering carbon fibers with polymeric porphyrin followed
by a Nafion coating, to detect NO released from a single cell [71]. The Nafion coating was essential
in the probe development since it is negatively charged and allows NO to pass through the coating
while blocking the passage of nitrite and nitrate, two main downstream components of NO, to the
sensor [71]. Shortly thereafter, Malinski’s lab showed the ability of an electrochemical probe to detect
NO within the vasculature of a living human and demonstrated dose dependent changes with their
system [72].
Since the original development of the electrochemical NO sensor, commercialization has led
to relatively inexpensive, user-friendly instruments consisting of various materials and allowing
for real-time in vitro and in vivo measurements of NO within a solution. One of the commercially
available systems is amiNO (produced by Innovative Instruments, Inc., Tampa, FL, USA), which allows
consumers to choose the size, flexibility, durability, sensitivity, and response time for their system,
has a detection limit of 1 nM of NO, and can differentiate between 10 nM and 11 nM solutions [73].
Two substantial drawbacks of the electrochemical sensor are that it has not been miniaturized to the
point of providing information about NO concentrations throughout a cell and it is not a sensor that
can monitor NO over long time intervals while a subject is carrying out natural activities, both of
which would be extremely valuable in understanding NO’s physiological importance.
4. Chemiluminescent Probes
Chemiluminescent probes can be used to detect NO in both liquid and gaseous samples [74–77].
The general scheme for the detection of NO in fluid samples via chemiluminescence is through the
activation of guanylyl cyclase by NO exposure, causing guanosine triphosphate (GTP) to be converted
to guanosine 30 ,50 -cyclic monophosphate (cGMP) which results in the release of pyrophosphate,
which can then interact with adenosine triphosphate sulfurylase (ATP-sulfurylase) to form ATP [76,77].
The ATP that is formed through this series of reactions is then able to interact with a luciferin-luciferase
system to emit light at 560 nm [76,77]. An advantage of the chemiluminescent system is that it is able
to detect NO at nM concentrations, since the initial guanylyl cyclase interaction with NO leads to
a 200-fold linear increase [76,77]. Chemiluminescent probes have some disadvantages, including the
inability to detect NO in vivo.
5. Fluorescence Probes
Fluorescence detection methods are an attractive alternative to the previously mentioned sensors
because of their ability to detect both extracellular and intracellular NO as well as their ability
to provide both spatial and temporal information [78]. Various types of fluorescent NO sensors
have been developed, including o-diamino aromatic compounds, luminescent lanthanide complexes,
transition-metal complexes, quantum dots, and carbon nanotube sensors. Each type of fluorescent
sensor has different positive and negative traits; in the following, some of the major fluorescent sensors
are listed with a discussion of their benefits and drawbacks.
A common approach for the generation of NO sensors is through the use of o-diamino aromatic
molecules (as depicted in Figure 4) such as 4,5-diaminofluorescein, commonly known as DAF-2 [79–82].

Chemosensors 2018, 6, 8

5 of 13

Unfortunately, many of the o-diamino sensors have drawbacks, including a false positive signal when
exposed to dehydroascorbic acid (DHA) and ascorbic acid (AA), which often co-localize with NO
synthase, and a sensitivity to pH [83–85]. The Shear research group developed a new NO sensor
in 2010, named NO550 , that has a high specificity, does not react to co-localized proteins, and is not
Chemosensors 2018, 6, x
5 of 13
sensitive
to pH differences, which is advantageous since various intracellular compartments
have
differentwhen
pH values
NO550 shows
red-shifted
1500-fold
increase
inoften
fluorescence
exposed[86–88].
to dehydroascorbic
acid a
(DHA)
and ascorbic
acid (AA),
which
co-localizeand
withdoes not
react to NO
other
reactive
and to
nitrogen
species
[88]. research
One drawback
of NO550
is that
has limited
synthase,
andoxygen
a sensitivity
pH [83–85].
The Shear
group developed
a new
NO it
sensor
in
2010,
named
NO
550
,
that
has
a
high
specificity,
does
not
react
to
co-localized
proteins,
and
is
not
aqueous solubility, making it less than ideal for biological studies [88].
sensitive
to
pH
differences,
which
is
advantageous
since
various
intracellular
compartments
have
An alternate method for NO fluorescence detection is through the use of transition metal-based
different pH values [86–88]. NO550 shows a red-shifted 1500-fold increase in fluorescence and does
complexes, which create a turn-on fluorescent signal. For transition metal-based complexes a fluorophore
not react to other reactive oxygen and nitrogen species [88]. One drawback of NO550 is that it has
is bound
to a transition metal and exhibits a very weak signal, but a reaction with NO causes the
limited aqueous solubility, making it less than ideal for biological studies [88].
displacementAnofalternate
the fluorophore
and
recoveryis[89,90].
metal-based
complexes
method for
NOfluorescence
fluorescence detection
throughUnfortunately,
the use of transition
metal-based
are water-insoluble
creating
a
good
NO
sensor
for
organic
solvents
but
not
being
optimal
complexes, which create a turn-on fluorescent signal. For transition metal-based complexes for
a many
fluorophore
is
bound
to
a
transition
metal
and
exhibits
a
very
weak
signal,
but
a
reaction
with
NO
biological scenarios [91].
causes the
displacement
of theisfluorophore
andbe
fluorescence
recovery
[89,90]. Unfortunately,
metal-sensors,
Because
aqueous
solubility
believed to
an important
characteristic
for biological
based complexes are water-insoluble creating a good NO sensor for organic solvents but not being
Nagano’s group developed a luminescent lanthanide complex that showed a 50-fold increase in
optimal for many biological scenarios [91].
luminescence
(excitation
nm and
emission
980
after characteristic
exposure tofor50biological
uM aqueous
Because
aqueous500
solubility
is believed
to be
an nm)
important
sensors,NO [92].
3+ complexes lies in the fact that their probe
A benefit
of
Nagano’s
sensor
over
previously
developed
Yb
Nagano’s group developed a luminescent lanthanide complex that showed a 50-fold increase in
luminescence
(excitation
500 nm
and
980 wavelength
nm) after exposure
to 50be
uMproduced
aqueous NO
A
is functional
in aqueous
systems,
has
anemission
excitation
that can
via[92].
two-photon
benefit
of has
Nagano’s
sensor over
previouslyin
developed
Yb3+ complexes
lies where
in the fact
that and
their blood
probe absorb
technology,
and
an emission
wavelength
the near-infrared
region,
water
functional in aqueous systems, has an excitation wavelength that can be produced via two-photon
minimalis light
[92].
technology, and has an emission wavelength in the near-infrared region, where water and blood
In 2017,
a
new fluorescent NO sensor called NCNO, which is based on N-nitrosation reactivity was
absorb minimal light [92].
developed to
avoid
reactions
from
DHA,
AA,
andisreactive
species
[93]. NCNO
In 2017, a non-specific
new fluorescent
NO sensor
called
NCNO,
which
based on oxygen
N-nitrosation
reactivity
covalently
a two-photon
fluorophore
to a mono
p-phenylenediamine,
as shown
wasbinds
developed
to avoid non-specific
reactions
fromalkyl-substituted
DHA, AA, and reactive
oxygen species [93].
NCNO
covalently
a two-photon fluorophore
fluorophore tohas
a mono
alkyl-substituted
p-phenylenediamine,
in Figure
4 [93].
Becausebinds
the two-photon
an emission
wavelength
greater than 600 nm,
as shown
Figure
[93]. Because
thewithin
two-photon
has an
emission
the NCNO
probeincan
be 4detected
deep
tissuefluorophore
and has been
shown
to wavelength
detect NO greater
generation in
than 600 nm, the NCNO probe can be detected deep within tissue and has been shown to detect NO
an ischemia reperfusion injury mouse model [93]. One of the shortcomings of the NCNO detection
generation in an ischemia reperfusion injury mouse model [93]. One of the shortcomings of the
system is
that detection
N-nitrosation
not total
NO concentration,
so assumptions
and models need
NCNO
systemisis detected,
that N-nitrosation
is detected,
not total NO concentration,
so assumptions
to be used
determine
actual
NO concentration
in the
solution/tissue.
andto
models
need tothe
be used
to determine
the actual NO
concentration
in the solution/tissue.

Figure 4. Comparison of a common o-diamino aromatic probe with the new NCNO probe. (a) shows

Figure 4.
Comparison of a common o-diamino aromatic probe with the new NCNO probe. (a) shows
a generic o-diamino aromatic probe that is activated by exposure to nitric oxide (NO),
a generic
o-diamino aromatic
probe
is activated
to nitric
oxide
(NO),
dehydroascorbic
acid (DHA),
or that
ascorbic
acid (AA);by
(b)exposure
shows the NCNO
probe
that
is alsodehydroascorbic
activated
acid (DHA),
orbut
ascorbic
acid (AA);
(b) shows the NCNO probe that is also activated by NO, but not by
by NO,
not by DHA
or AA [93].
DHA or AA [93].
Quantum dots (QDs) are a class of nanoparticles that can fluoresce at many different
wavelengths (with narrow emission spectra), do not quickly photobleach, and emit light more than
Quantum
dots (QDs) are a class of nanoparticles that can fluoresce at many different wavelengths
100 times stronger than organic dyes [91,94]. Quantum dots have been shown to be excellent turn
(with narrow
emission
spectra),
doanalytes
not quickly
emit light more
than 100
on/off chemosensors
for various
throughphotobleach,
the attachmentand
of analyte-sensitive
molecules
to times

stronger than organic dyes [91,94]. Quantum dots have been shown to be excellent turn on/off

Chemosensors 2018, 6, 8
Chemosensors 2018, 6, x

6 of 13
6 of 13

the QD’s surface.
A recent
turn on
fluorescence
sensor for
called Fe(III)-QD-nanoprobe,
was
chemosensors
for various
analytes
through
the attachment
of NO,
analyte-sensitive
molecules to the QD’s
developed
withturn
CdSe-ZnS
QDs providing
the called
base/fluorescent
portion of
sensor with
and
surface.
A recent
on fluorescence
sensor for NO,
Fe(III)-QD-nanoprobe,
wasthe
developed
tris(dithiocarbamato)iron(III)
acting as the NO portion
responsive
molecules
[95].
The Fe(III)-QD-nanoprobe
CdSe-ZnS
QDs providing the base/fluorescent
of the
sensor and
tris(dithiocarbamato)iron(III)
exhibited
a dose-dependent
NO The
thatFe(III)-QD-nanoprobe
was stable for over anexhibited
hour andaspecificity
to NO
acting
as the
NO responsive response
moleculesto[95].
dose-dependent
when compared
nitrite,
andover
other
oxygen/nitrogen
species
[95].
Unfortunately,
the
response
to NO to
that
was nitrate,
stable for
anreactive
hour and
specificity to NO
when
compared
to nitrite,
Fe(III)-QD-nanoprobe
is irreversibly
altered species
by exposure
to NO and can the
therefore
only be used forisa
nitrate,
and other reactive
oxygen/nitrogen
[95]. Unfortunately,
Fe(III)-QD-nanoprobe
single trial. Yet,
since
was the
firstand
published
example
of be
a QD
sensor
NO,
it isYet,
possible
irreversibly
altered
by this
exposure
to NO
can therefore
only
used
for a for
single
trial.
since that
this
further
optimization
will
allow
the
sensor
to
recover
and
be
used
for
multiple
cycles
[95].
was the first published example of a QD sensor for NO, it is possible that further optimization will
nanotubes
are and
another
classfor
ofmultiple
nanoparticles
allowCarbon
the sensor
to recover
be used
cycles that
[95].have recently been shown to act as a
biological
sensor
[96–98].are
Carbon
nanotubes
a diverse group
of particles
that
perform
Carbon
nanotubes
another
class of are
nanoparticles
that have
recently
been
showndifferently
to act as
depending
on
their
chirality
(the
angle
of
their
carbon
bonds
in
relation
to
the
tube’s
direction)
a biological sensor [96–98]. Carbon nanotubes are a diverse group of particles that perform differently
[99,100]. Semiconducting
single-wall
(SWNT)
are one-dimensional,
pure[99,100].
carbon
depending
on their chirality
(the angle carbon
of their nanotubes
carbon bonds
in relation
to the tube’s direction)
substances that single-wall
fluoresce in
the near-infrared
regionare
(900–1500
nm) when
excited
visible light
Semiconducting
carbon
nanotubes (SWNT)
one-dimensional,
pure
carbonby
substances
that
(500–850 nm)
The wavelength
at which
SWNT
(with
a narrow
emission
spectrum)
fluoresce
in the[99,101].
near-infrared
region (900–1500
nm)
whenfluoresce
excited by
visible
light (500–850
nm)
[99,101].
is dependent
on their
chirality,
andfluoresce
therefore,(with
similar
to QDs, emission
multiple SWNT
can is
bedependent
differentiated
The
wavelength
at which
SWNT
a narrow
spectrum)
on
within
a
single
solution
[101,102].
The
Strano
research
group
developed
NO
sensors
by
wrapping
their chirality, and therefore, similar to QDs, multiple SWNT can be differentiated within a single
SWNT with
specific
polymers,
including
3,4-diaminophenyl-functionalized
dextran
short
solution
[101,102].
The Strano
research
group developed
NO sensors by wrapping SWNT
withorspecific
oligonucleotide
sequences
such as (AAAT)7 and (AT)dextran
15, that display
change in fluorescence
intensity
polymers,
including
3,4-diaminophenyl-functionalized
or shortaoligonucleotide
sequences
such as
when exposed
to 15
NO,
asdisplay
depicted
in Figure
5 [103–105].intensity
The SWNT
sensors
have
many
(AAAT)
, that
a change
in fluorescence
when
exposed
to NO,
asadvantages
depicted in
7 and (AT)
over other
fluorescence
sensors
including
lackadvantages
of photobleaching,
ability
to be detected
Raman
Figure
5 [103–105].
The SWNT
sensors
havethe
many
over other
fluorescence
sensorsby
including
scattering
in
addition
to
their
fluorescent
signal,
and
emission
in
the
near
infrared
range
where
blood
the lack of photobleaching, ability to be detected by Raman scattering in addition to their fluorescent
and water
not absorb
a large
percent of
lightwhere
[106–109].
shortcoming
of the
current
SWNT-based
signal,
anddo
emission
in the
near infrared
range
bloodAand
water do not
absorb
a large
percent of
NO sensors
is that
they are turn
off current
fluorescence
sensors,NO
adding
a layer
difficulty
the
long-term
light
[106–109].
A shortcoming
of the
SWNT-based
sensors
is thatofthey
are turntooff
fluorescence
detectionadding
of NOawithin
system [103–105].
sensors,
layer ofa difficulty
to the long-term detection of NO within a system [103–105].

Figure
a single
wallwall
carbon
nanotube
sensorsensor
for nitric
detection.
The nanotube
Figure 5.
5. Schematic
Schematicofof
a single
carbon
nanotube
foroxide
nitric(NO)
oxide
(NO) detection.
The
is
excited
by
a
561
nm
laser
and
emits
990
nm
fluorescence
when
there
is
no
NO
present,
but
when
NO is
nanotube is excited by a 561 nm laser and emits 990 nm fluorescence when there is no NO
present,
added to the system the fluorescence of the carbon nanotube is quenched [104,105].
but when NO is added to the system the fluorescence of the carbon nanotube is quenched [104,105].

6.
Genetic Biosensors
Biosensors
6. Genetic
An
new way
An interesting
interesting new
way to
to detect
detect NO
NO within
within aa single
single cell
cell is
is through
through the
the addition
addition of
of genetic
genetic
materials
materials that
that will
will code
code for
for aa visual
visual signal
signal response
response in
in the
the presence
presence of
of NO
NO [110].
[110]. Ronald
Ronald Malli
Malli and
and
colleagues
developed
a
system
in
which
the
NO
responsive
transcription
factor
of
Escherichia
coli
(E.
coli)
colleagues developed a system in which the NO responsive transcription factor of Escherichia coli (E. coli)
is
conjugated
to
fluorescent
protein
variants
that
are
then
taken
up
by
cells
[110–112].
When
these
is conjugated to fluorescent protein variants that are then taken up by cells [110–112]. When these
fluorescent
with
HeLa
cells
theythey
werewere
shown
to beto
taken
up andup
expressed
at similar
fluorescent probes
probeswere
weretested
tested
with
HeLa
cells
shown
be taken
and expressed
at
rates
compared
to
other
genetically
encoded
probes
[110].
The
NO
probes
were
shown
to
respond
to
similar rates compared to other genetically encoded probes [110]. The NO probes were shown to
NO
immediately
a reversible
signal,
allowing for
long allowing
term NO dynamics
within
respond
to NO with
immediately
with
a reversible
signal,
for long investigations
term NO dynamics
cells
in vitro [110].
Ongoing
efforts
are looking
at the
possibility
of utilizing
system to
investigations
within
cells inresearch
vitro [110].
Ongoing
research
efforts
are looking
at thethis
possibility
of
develop
an
in
vivo
model
[110].
One
major
obstacle
that
still
prevents
the
utilization
of
the
probes
utilizing this system to develop an in vivo model [110]. One major obstacle that still prevents the
in
vivo is that
theprobes
fluorescence
range
that is currently
being
utilized
difficult being
to visualize
at
utilization
of the
in vivoemission
is that the
fluorescence
emission
range
that isiscurrently
utilized
any
depth
within
tissue.
is difficult to visualize at any depth within tissue.

Chemosensors 2018, 6, 8

7 of 13

Table 1. Overview of the nitric oxide (NO) sensing methods discussed in this review with the assay/instruments’ molecule and rate of detection, sensitivity, scale,
strengths and current drawbacks outlined.
Detection Method

Sensitivity

Molecule Detected

Rate of Detection

Scale

In Vivo, In Vitro, Both

Strengths
Availability, NO2 is stable and
provides an estimate of NO in
the system

Drawbacks
Does not detect NO directly,
inconsistent results from system
to system

Availability, L-citrulline is stable
and estimates NO generated
by NOS
Availability, Real-time detection,
High sensitivity

Does not detect NO directly,
natural L-arginine sources will
interfere with readings
Detects on a system level, cannot
detect over long time intervals

Griess Assay [58–60]

1.0 µM

NO2

End-Point

System

In Vitro

NOS Activity Assay [61,67]

5.0 µU

L-Citrulline

End-Point

System

In Vitro

Electrochemical Probe [71–73]

1.0 nM

NO

Real-Time

System

Both

50 pM

NO

End-Point

System

In Vitro

High sensitivity to NO

5.0 µM

NO

Real-Time

Single Cell

In Vitro

Real-time detection of NO at
a cellular level

~0.5 µM

NO, N-Nitrosation

Real-Time

Single Cell

Both

4.0 µM

NO

Real-Time

System

In Vitro

Quantum Dots [95]

3.3 µM

NO

Real-Time

Single Cell

Both

Carbon Nanotubes [103–105]

1.0 µM

NO

Real-Time

Single Cell

Both

Genetic Biosensors [110]

50–94 nM

NO

Real-Time

Single Cell

In Vitro

Chemiluminescent
Probes [76,77]
o-diamino Aromatic
Compounds [83,86,88]
Luminescent Lanthanide
Complexes [92]
Transition-Metal
Complexes [90,91]

Real-time detection at
a cellular level
Sensitivity, real-time detection
of NO
Real-time detection of NO at
a cellular level
Real-time detection of NO at
a cellular level
Real-time detection of NO at
a cellular level

Detects on a system level, Cannot
detect in vivo
Limited aqueous solubility, false
positives with DHA and AA
Does not detect NO directly
Limited aqueous solubility
Irreversibly altered by NO
Turn off sensing of NO
Fluorescence emission is not
detectable through tissue
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7. Conclusions
Nitric oxide is an essential reactive species within biological systems. As researchers are able to
understand the many complex reactions associated with NO, a deeper understanding of healthy and
diseased cells, tissues, and organisms will be uncovered. Before researchers can understand NO’s
role in biological functions there must be a way to accurately measure NO both in vitro and in vivo.
Current sensor methods, many of which are outlined in Table 1, are greatly improved over those from
just 10 or 20 years ago, and hopefully further progress can be made within the coming years.
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